Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein, known as HERPUD1, is a protein encoded by the HERPUD1 gene in humans . HERPUD1 is a key component of the endoplasmic reticulum (ER) protein quality control mechanism . It is involved in ER-associated degradation (ERAD), which is an ER-resident protein quality control mechanism . HERPUD1 may play a role in both the unfolded protein response (UPR) and ERAD .
HERPUD1 functions as one of the main components of ER-associated degradation, which is an ER-resident protein quality mechanism . HERPUD1 is upregulated under ER stress, a condition reported to cause ER membrane expansion and remodeling . It has been shown that HERPUD1 regulates ERAD by interacting with proteins involved in the retrotranslocation, ubiquitination, and degradation of misfolded proteins . HERPUD1 is one of the critical components involved in stabilizing the ERAD multiprotein complex and effectively directs misfolded proteins to degradation and is thought to be one of the major components of ERAD .
HERPUD1 has been proposed as one of the significant components of ERAD, which acts as a structure-scaffolding protein in the ER membrane . It acts as a shuttle protein in the retrotranslocation step of ERAD and has no known enzyme activity . Moreover, HERPUD1 controls the proteasomal degradation of the inositol 1,4,5-triphosphate receptor and ryanodine receptor proteins, which is a $$Ca^{+2}$$ channel and has a critical role in $$Ca^{+2}$$ homeostasis .
HERPUD1 is necessary for adequate insulin-induced glucose uptake due to its role in $$Ca^{2+}$$/calcineurin regulation in L6 myotubes .
The accumulation of unfolded proteins in the endoplasmic reticulum (ER) triggers the ER stress response . This response includes the inhibition of translation to prevent further accumulation of unfolded proteins, the increased expression of proteins involved in polypeptide folding, known as the unfolded protein response (UPR), and the destruction of misfolded proteins by the ER-associated protein degradation (ERAD) system . HERPUD1's expression is induced by UPR, and it has an ER stress response element in its promoter region . The encoded protein has an N-terminal ubiquitin-like domain which may interact with the ERAD system .
HERPUD1 interacts in the ER membrane with Hrd1/SYVN1, an E3 ligase enzyme responsible for protein ubiquitination required to target misfolded proteins to proteasomal degradation, ubiquitin molecule, adaptor subunit SEL1L, OS-9 acting as a lectin, and Derlin1, which is proposed as a component of the channel complex . HERPUD1 has been shown to interact with UBQLN1 and UBQLN2 .
HERPUD1 functions as one of the main components of the ER protein quality control mechanism, which has been recommended as a good target for the treatment of many cancer types . HERPUD1 may be a good target for suppressing tumorigenesis in breast cancer cells .
HERPUD1 plays a significant role in the regulation of $$Ca^{2+}$$ levels, possibly by modulating IP3R degradation . Herpud1 plays a significant role in the regulation of $$Ca^{2+}$$ levels and has a potential role in anti-hypertrophic mechanisms .
Stabilized HERPUD1 downregulates macroautophagy, favoring instead a closed interplay between the ER and lysosomes with consequences in drug-cell . Stabilized HERPUD1 through the deletion of its UBL domain causes a decrease in basal and induced autophagy . Additionally, it promotes an ER remodeling independent of the unfolded protein response activation into stacked tubular structures resembling previously described tubular ER rearrangements . Higher HERPUD1 stability has a positive impact in lysosomal function, promoting an expanded ER-lysosomal network . The phosphomimetic S59D mutant within the UBL domain of HERPUD1 mimics the effect of the UBL deletion and reduces basal and induced autophagy and remodeling of the ER-lysosomal network with the presence of ER-lysosomal membrane-contact sites, together promoting drug-stress cell survival .
HERPUD1 functions as an essential component of the endoplasmic reticulum-associated degradation (ERAD) complex, which is responsible for identifying, ubiquitinating, and eliminating misfolded proteins from the ER. It specifically participates in IP3R1 (inositol 1,4,5-trisphosphate receptor) degradation and calcium signaling regulation, making it a critical factor in maintaining cellular calcium homeostasis . HERPUD1 acts as a scaffold protein that helps organize functional retrotranslocation complexes in HRD1-mediated ERAD, facilitating the recruitment of other components necessary for the ERAD machinery to function properly .
HERPUD1 contains several functionally distinct domains that contribute to its role in ERAD:
A ubiquitin-like (UBL) domain at the N-terminus, which is critical for its function in the ERAD pathway
A long hydrophobic segment near the C-terminal region that facilitates membrane association
Unlike its yeast homolog Usa1p, HERPUD1 does not regulate HRD1 stability or oligomerization status, but instead helps recruit DERL2 to the HRD1-SEL1L complex, highlighting evolutionary divergence in function .
HERPUD1 expression is significantly upregulated in response to various cellular stressors. Experimental data shows:
Treatment with tunicamycin (10μg/ml for 12h), an ER stress inducer, increases HERPUD1 protein levels by approximately 6.5-fold (p<0.05) in cultured neonatal rat ventricular myocytes (NRVMs)
Oxidative stress induced by H₂O₂ (100μM for 2h) increases HERPUD1 protein levels by about 1.3-fold (p<0.05) in NRVMs
This stress-responsive upregulation suggests HERPUD1 is part of an adaptive cellular mechanism to protect against various forms of cellular stress, particularly in cardiac tissue.
Based on the latest research, several experimental models have proven effective for HERPUD1 research:
Genetic knockout models: Herpud1-knockout mice exhibit cardiac hypertrophy and dysfunction, making them an excellent model for studying HERPUD1's role in cardiac pathophysiology
Cell culture systems:
Stress induction models:
These models allow for comprehensive assessment of HERPUD1 function in both physiological and pathological contexts.
Several complementary techniques have proven valuable for studying HERPUD1 interactions:
Co-immunoprecipitation: Highly effective for identifying components of the HERPUD1-containing complexes. Using HRD1 antibodies, researchers have successfully co-precipitated endogenous SEL1L, DERL2, HERP1, and HERP2, confirming that HERPUD1 is part of the HRD1-SEL1L-DERL2 complex
FLAG-tag immunoprecipitation: Expression of FLAG-tagged HERP1 or HERP2 followed by immunoprecipitation with FLAG antibodies can be used to study interactions with HRD1, SEL1L, and DERL2
RNA interference combined with biochemical analysis: Depleting HERP1 and/or HERP2 via siRNA followed by analysis of substrate degradation provides insights into functional roles within the ERAD complex
These methods have revealed that HERP1 and HERP2 can form hetero-oligomers either directly or through the HRD1 complex, suggesting functional redundancy .
HERPUD1 functions as a negative regulator of pathological cardiac hypertrophy primarily through its regulation of IP3R protein levels. The mechanistic pathway involves:
HERPUD1 facilitates the degradation of IP3R through the ERAD pathway
In the absence of HERPUD1 (knockout mice or siRNA-treated cardiomyocytes), IP3R levels become elevated
Elevated IP3R leads to increased cytosolic and nuclear Ca²⁺ levels
Altered calcium signaling activates hypertrophic pathways
This results in increased expression of hypertrophic markers and development of pathological cardiac hypertrophy
This mechanism establishes HERPUD1 as a novel regulator of cardiac pathophysiology through its effects on calcium homeostasis.
HERPUD1 plays a protective role against both ER stress and oxidative stress in cardiomyocytes. Experimental evidence demonstrates:
Downregulation of HERPUD1 by siRNA in NRVMs exacerbates ER stress markers:
HERPUD1 knockdown significantly impairs mitochondrial function:
Under oxidative stress conditions (H₂O₂ treatment), HERPUD1 downregulation results in:
These findings establish HERPUD1 as a critical protective factor against stress-induced cardiac injury and mitochondrial dysfunction.
HERPUD1 serves as an essential adaptor protein in the HRD1-mediated ERAD pathway. Key findings regarding this interaction include:
HERPUD1 interacts with HRD1 through a region located in the cytosol
Unlike its yeast homolog (Usa1p), HERPUD1 does not regulate HRD1 stability or oligomerization status
HERPUD1 helps recruit DERL2 to the HRD1-SEL1L complex, which is critical for forming an active retrotranslocation complex
The UBL domain of HERPUD1 has functions independent of DERL2 recruitment in ERAD
Both HERPUD1 and HERPUD2 can co-exist in the same HRD1-SEL1L complex, suggesting potential functional redundancy or cooperation
Immunoprecipitation experiments confirm that endogenous SEL1L, DERL2, HERP1, and HERP2 can be co-precipitated with HRD1, indicating that they form part of the same multi-protein complex in mammalian cells .
HERPUD1 and HERPUD2 share significant structural and functional similarities:
Sequence homology: HERPUD2 shares 38% sequence identity and 51% homology with HERPUD1
Domain structure: Similar to HERPUD1, HERPUD2 contains a ubiquitin-like (UBL) domain at the N terminus and a long hydrophobic segment near the C-terminal region
Functional redundancy: Experimental evidence shows that:
Depletion of either HERPUD1 or HERPUD2 individually does not cause significant stabilization of certain ERAD substrates (e.g., SHH N278A)
Simultaneous depletion of both HERP proteins results in strong inhibition of substrate degradation
Both proteins can form hetero-oligomers either directly or through the HRD1 complex
This partial functional redundancy explains why some ERAD substrates are only significantly stabilized when both HERP proteins are depleted, suggesting an evolved safeguard mechanism for this critical cellular quality control system.
When working with recombinant HERPUD1 protein, researchers should consider:
Expression systems: Human cell lines (particularly 293T cells) have been successfully used to express HERPUD1 proteins with epitope tags (such as FLAG)
Protein solubilization: Given HERPUD1's membrane association, appropriate detergent conditions must be optimized for extraction while maintaining protein-protein interactions
Buffer considerations: When studying interactions with other ERAD components, buffers that preserve membrane protein complexes are essential
Tag selection: His-tagged versions of HERPUD1 (such as AA 1-263) are commercially available and have been used in research applications
Functional validation: Assessment of recombinant HERPUD1 activity can be performed through its ability to bind known interaction partners (HRD1, DERL2) and/or complement HERPUD1-deficient cell lines
Several complementary approaches can be employed:
Substrate stabilization assays: Using model ERAD substrates like SHH (Sonic Hedgehog) and NHK (Null Hong Kong alpha-1-antitrypsin) in cells with HERPUD1 knockdown or knockout
Ubiquitination analysis: Assessing the ubiquitination status of ERAD substrates in the presence or absence of HERPUD1
Calcium signaling measurements: Given HERPUD1's role in IP3R regulation, measuring cytosolic and nuclear Ca²⁺ levels using appropriate indicators
Mitochondrial function assays: Oxygen consumption rate (OCR) measurements to assess how HERPUD1 affects mitochondrial function under stress conditions
Cell viability assays: Quantitative assessment of cell survival under various stress conditions with cell titer blue assay or similar methods
These methodologies provide comprehensive insights into HERPUD1's multifaceted roles in protein quality control and cellular stress responses.